Preliminary results from the US Food and Drug Administration's (FDA's) mandated postmarket surveillance studies of duodenoscopes show "higher-than-expected" contamination rates after reprocessing, according to an article on the Medscape website.
The FDA said 3 percent of properly collected samples tested positive for more than 100 colony-forming units of "low-concern" organisms.
These organism are unlikely to cause serious infections but are, nevertheless, an indication of a "reprocessing failure."
An additional 3 percent of properly collected samples tested positive for "high-concern" bacteria that are more often associated with disease.
What To Know Now About OSHA's Updated Hazcom Rule
HealthSource of Ohio and UC Health Partner for New Medical Office Building
NorthShore Health Centers Investigates Data Security Incident 
Healthcare Ransomware Attacks Reach Record High in Q3 2026
Bon Secours Mercy Health Acquires Fauquier Health